Cabaletta Bio
$7.289876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.70 (-8.77%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Cabaletta Bio and other stocks, options, ETFs, and crypto commission-free!
About CABA
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. Read More The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
Employees
—
Headquarters
Philadelphia, Pennsylvania
Founded
2017
Market Cap
179.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
98.10K
High Today
$7.56
Low Today
$7.18
Open Price
$7.56
Volume
113.83K
52 Week High
$19.63
52 Week Low
$5.51
Collections
CABA Earnings
Q4 2019
Estimated
— per share
Actual
Expected Apr 13, Pre-Market